The Dysarthrias of Shy-Drager Syndrome

1979 ◽  
Vol 44 (1) ◽  
pp. 55-60 ◽  
Author(s):  
Craig Linebough
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Motor System ◽  
Degenerative Disease ◽  
Cerebellar Dysfunction ◽  
Motor Speech ◽  
System Involvement ◽  
The Central Nervous System

Shy-Drager syndrome is a degenerative disease of the central nervous system that may include among its signs some form of dysarthria. Of 80 patients with Shy-Drager syndrome, 35 presented some form of dysarthria. Of these, 15 presented dysarthria indicative of cerebellar dysfunction, 11 with dysarthria indicating involvement of the striatum, and nine with various mixed dysarthrias indicative of multiple motor system involvement. The results of this study reaffirm the value of assessing motor speech in the differential diagnosis of neuromotor impairments and emphasize the importance of maintaining effective modes of communication for patients having progressive disorders.

CRYPTOCOCCOSIS (TORULOSIS) IN CHILDREN

PEDIATRICS ◽  
1964 ◽  
Vol 34 (3) ◽  
pp. 393-400
Author(s):  
C. M. F. Siewers ◽  
Henry G. Cramblett
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Amphotericin B ◽  
Central Nervous System Involvement ◽  
Pulmonary Involvement ◽  
System Involvement ◽  
Unexplained Fever ◽  
The Central Nervous System

Four cases of disseminated cryptococcosis in children are reported, two of whom had cryptococcosis without involvement of the central nervous system. All but one patient, a child with leukemia, survived. Two of the survivors were treated with amphotericin B intravenously, while one child recovered after long-term sulfadiazine therapy. Cryptococcosis should be considered in the differential diagnosis of disease in children with unexplained fever, lymphadenopathay, hepatosplenomegaly, or pulmonary involvement. Central nervous system involvement is not invariably present, and can be prevented if therapy with amphotericin B is instituted early. The necessity of appropriate and repeated fungal cultures is emphasized.

Stroke due to isolated angiitis ot the central nervous system (CNS) – differential diagnosis and therapy

2004 ◽  
Vol 35 (01) ◽  
Author(s):  
S Springer ◽  
S Bechthold ◽  
A Jansson ◽  
K Kurnik ◽  
T Pfluger ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Diagnosis And Therapy ◽  
The Central Nervous System

scholarly journals Acute Disseminated Encephalomyelitis (ADEM): A Demyelinating Disease with Specific Morphological Features

2021 ◽  
pp. 106689692199356
Author(s):  
Fleur Cordier ◽  
Lars Velthof ◽  
David Creytens ◽  
Jo Van Dorpe
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Clinical Case ◽  
Demyelinating Disease ◽  
Acute Disseminated Encephalomyelitis ◽  
Demyelinating Diseases ◽  
Demyelinating Disorder ◽  
Immune Mediated ◽  
The Central Nervous System

Acute disseminated encephalomyelitis (ADEM) is a rare immune-mediated inflammatory and demyelinating disorder of the central nervous system. Its characteristic perivenular demyelination and inflammation aid in the differential diagnosis with other inflammatory demyelinating diseases. Here, we present a clinical case of ADEM, summarize its histological hallmarks, and discuss pitfalls concerning the most important neuropathological differential diagnoses.

scholarly journals Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?

2021 ◽  
Author(s):  
Elias Manca
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Human Body ◽  
Lupus Erythematosus ◽  
Neuropsychiatric Symptoms ◽  
Systemic Lupus ◽  
Neuropsychiatric Systemic Lupus Erythematosus ◽  
The Central Nervous System

AbstractSystemic lupus erythematosus is a complex immunological disease where both environmental factors and genetic predisposition lead to the dysregulation of important immune mechanisms. Eventually, the combination of these factors leads to the production of self-reactive antibodies that can target any organ or tissue of the human body. Autoantibodies can form immune complexes responsible for both the organ damage and the most severe complications. Involvement of the central nervous system defines a subcategory of the disease, generally known with the denomination of neuropsychiatric systemic lupus erythematosus. Neuropsychiatric symptoms can range from relatively mild manifestations, such as headache, to more severe complications, such as psychosis. The evaluation of the presence of the autoantibodies in the serum of these patients is the most helpful diagnostic tool for the assessment of the disease. The scientific progresses achieved in the last decades helped researchers and physicians to discover some of autoepitopes targeted by the autoantibodies, although the majority of them have not been identified yet. Additionally, the central nervous system is full of epitopes that cannot be found elsewhere in the human body, for this reason, autoantibodies that selectively target these epitopes might be used for the differential diagnosis between patients with and without the neuropsychiatric symptoms. In this review, the most relevant data is reported with regard to mechanisms implicated in the production of autoantibodies and the most important autoantibodies found among patients with systemic lupus erythematosus with and without the neuropsychiatric manifestations.

First Presentation of an Acquired Demyelinating Syndrome

2017 ◽  
Vol 16 (03) ◽  
pp. 164-170
Author(s):  
Rachel Gottlieb-Smith ◽  
Amy Waldman
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Optic Neuritis ◽  
Clinical Features ◽  
Neuromyelitis Optica ◽  
Transverse Myelitis ◽  
Acute Disseminated Encephalomyelitis ◽  
The Central Nervous System

AbstractAcquired demyelinating syndromes (ADS) present with acute or subacute monofocal or polyfocal neurologic deficits localizing to the central nervous system. The clinical features of distinct ADS have been carefully characterized including optic neuritis, transverse myelitis, and acute disseminated encephalomyelitis. These disorders may all be monophasic disorders. Alternatively, optic neuritis, partial transverse myelitis, and acute disseminated encephalomyelitis may be first presentations of a relapsing or polyphasic neuroinflammatory disorder, such as multiple sclerosis or neuromyelitis optica. The clinical features of these disorders and the differential diagnosis are discussed in this article.

Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment

2017 ◽  
Vol 25 (2) ◽  
pp. 497-501 ◽  
Author(s):  
João Godinho ◽  
Mafalda Casa-Nova ◽  
Teresa Mesquita ◽  
Maria João Baptista ◽  
Francisco Araújo ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Clinical Findings ◽  
Neurological Dysfunction ◽  
Toxic Encephalopathy ◽  
Central Nervous System Toxicity ◽  
Cerebellar Dysfunction ◽  
Oxaliplatin Treatment ◽  
Tumor Involvement ◽  
The Central Nervous System

Introduction Capecitabine is a fluoropyrimidine commonly used in the treatment of colorectal cancer which may cause central nervous system toxicity, namely cerebellar dysfunction. Case report We describe a 77-year-old man undergoing adjuvant treatment of colon cancer with capecitabine and oxaliplatin who presented with acute cerebellar ataxia and encephalopathy that progressed to coma. Diagnosis of toxic encephalopathy was made after the exclusion of alternative causes of neurological dysfunction and complete resolution of clinical findings with permanent discontinuation of chemotherapy. Discussion When patients with cancer develop symptoms and signs of central nervous dysfunction, metabolic and infectious causes plus tumor involvement of central nervous system must be sought. However, chemotherapy may also cause toxicity to the central nervous system. Capecitabine is no exception, although cerebellar dysfunction is rarely reported. Conclusion Although rare, capecitabine-induced encephalopathy may be severe and physicians should be aware of this possible side effect.

Studies in Embryonic and Larval Development in Amphibia

Development ◽  
1959 ◽  
Vol 7 (2) ◽  
pp. 128-145
Author(s):  
Arthur Hughes
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Larval Development ◽  
Motor System ◽  
Ventral Root ◽  
Basal Plate ◽  
Nerve Process ◽  
The Central Nervous System ◽  
Embryonic And Larval Development ◽  
Developing Nervous System

In 1913 G. E. Coghill initiated a series of papers on the neuro-embryology of the Urodele Ambystoma with a description of the earliest stages of the motor system of the trunk (Coghill, 1913). His main conclusion is stated early in the paper in these words: The neurones … which establish the earliest contact with the cells of the myotome are found in Amblystoma to be at the same time the neurones of the motor tract in the central nervous system. The primary ventral root fibre is a collateral of the tract cell. (Coghill, 1913, p. 121.) Thirteen years later, among a group of other papers on the developing nervous system of Ambystoma, he returned to this theme, and in a series of examples described the form of the first nerve process within the basal plate of the cord.

Sign in / Sign up

Export Citation Format

Share Document